Cunningham, MJ; Bock, HA; Serrano, IC; Bechand, B; Vidyadhara, DJ; Bonniwell, EM; Lankri, D; Duggan, P; Nazarova, AL; Cao, AB; Calkins, MM; Khirsariya, P; Hwu, C; Katritch, V; Chandra, SS; McCorvy, JD; Sames, D. Pharmacological mechanism of the non-hallucinogenic 5-HT2A agonist Ariadne and analogs ACS Chem. Neurosci., 15 Dec 2022, n/a. 15.3 MB. https://doi.org/10.1021/acschemneuro.2c00597 #30 MS,NMR,other
Duan, W; Cao, D; Wang, S; Cheng, J. Serotonin 2A receptor (5-HT2AR) agonists: Psychedelics and non-hallucinogenic analogues as emerging antidepressants Chem. Rev., 10 Jan 2024, 124 (1), 124–163. 12.6 MB. https://doi.org/10.1021/acs.chemrev.3c00375 #98
N-Cyclopropyl-2,5-dimethoxy-4-methylamphetamine · N-cPr-DOM
N-Pentyl-3,4-methylenedioxyamphetamine · MDAM
ETHYL-L · α-Bu-N-Et-MDPEA · α-Butyl-N-ethyl-3,4-methylenedioxyphenethylamine
4-Cyclopropylmethyl-2,5-dimethoxyamphetamine · DOCPM
O-DSMT · O-Desmethyltramadol
N-(t-Butoxycarbonyl)-N-methylamphetamine · N-t-BOC-MA